BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20844194)

  • 1. Combined administration of a mutant TGF-beta1/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance.
    Zhang W; Zhang D; Shen M; Liu Y; Tian Y; Thomson AW; Lee WP; Zheng XX
    J Immunol; 2010 Oct; 185(8):4750-9. PubMed ID: 20844194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.
    Yang H; Cheng EY; Sharma VK; Lagman M; Chang C; Song P; Ding R; Muthukumar T; Suthanthiran M
    Transplantation; 2012 Mar; 93(6):580-8. PubMed ID: 22270834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.
    Pothoven KL; Kheradmand T; Yang Q; Houlihan JL; Zhang H; Degutes M; Miller SD; Luo X
    Am J Transplant; 2010 Aug; 10(8):1774-84. PubMed ID: 20626386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
    Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
    Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection.
    Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X
    Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells.
    Francis RS; Feng G; Tha-In T; Lyons IS; Wood KJ; Bushell A
    Eur J Immunol; 2011 Mar; 41(3):726-38. PubMed ID: 21243638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Critical Role for TGF-β/Fc and Nonlytic IL-2/Fc Fusion Proteins in Promoting Chimerism and Donor-Specific Tolerance.
    Xu H; Zheng XX; Zhang W; Huang Y; Ildstad ST
    Transplantation; 2017 Feb; 101(2):294-301. PubMed ID: 27306533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
    Wang X; Wang W; Xu J; Le Q
    Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
    Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
    J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.
    Prochazkova J; Fric J; Pokorna K; Neuwirth A; Krulova M; Zajicova A; Holan V
    Immunology; 2009 Sep; 128(1 Suppl):e670-8. PubMed ID: 19740328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells.
    Kopf H; de la Rosa GM; Howard OM; Chen X
    Int Immunopharmacol; 2007 Dec; 7(13):1819-24. PubMed ID: 17996694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells.
    Wu C; Zhang Y; Jiang Y; Wang Q; Long Y; Wang C; Cao X; Chen G
    Cell Mol Immunol; 2013 Sep; 10(5):393-402. PubMed ID: 23872920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.
    Xu L; Kitani A; Fuss I; Strober W
    J Immunol; 2007 Jun; 178(11):6725-9. PubMed ID: 17513718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs.
    Kawamoto K; Pahuja A; Hering BJ; Bansal-Pakala P
    Transpl Immunol; 2010 May; 23(1-2):28-33. PubMed ID: 20307666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1 to Th2 immune deviation facilitates, but does not cause, islet allograft tolerance in mice.
    Zhang D; Sanchez-Fueyo A; Kawamoto K; Alexopoulos SP; Zhang W; Zheng XX
    Cytokine; 2010 Sep; 51(3):311-9. PubMed ID: 20598563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet allograft tolerance in the absence of invariant natural killer T cells.
    Chu X; Kilpatrick E; Xiao X; Liu W; Demirci G; Exley M; Li XC
    Clin Immunol; 2011 Dec; 141(3):268-72. PubMed ID: 21996456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.